Quotes: MENA   Enter Symbol: NewsLetter: Search: advanced

Experts in Africa cautious on potential malaria vaccine  Join our daily free Newsletter

MENAFN - AFP - 08/10/2013
No. of Ratings : 0
Add to Mixx!


(MENAFN - AFP) Experts in Africa, the continent worst-hit by malaria, reacted with optimism but also caution on Tuesday to news that the first vaccine against the killer disease may soon reach the market.

GlaxoSmithKline said it was seeking approval for a prototype vaccine that reduced the risk of malaria by almost half among children aged between five and 17 months, and by around a quarter among infants aged between six and 12 weeks.

"This is the first vaccine against malaria," Sophie Biernaux, a malaria vaccine leader at GSK, told AFP in Durban.

If the British drugmaker's application is successful, the vaccine could be rolled out within two years.

The mosquito-borne disease kills an estimated 660,000 people each year, 90 percent of them in Africa, with the majority being children under five.

"This is great hope for Africa," Nilton Saraivo, a manager of Angola's national anti-malaria programme, told AFP.

But others were more cautious.

In Gabon, one of the countries where clinical trials were conducted, researcher Bertrand Lell said the vaccine's efficacy "is not very large" compared to vaccines such as the one against polio.

"But given the prevalence of malaria in Africa, you can imagine the impact it will have on people if the mortality rate is down 50 percent," said Lell, of the Lambarene Centre for Medical Research.

In the Democratic Republic of Congo -- which has the world's second-highest malaria death rate after Nigeria -- SANRU, an organisation that distributes mosquito nets to fight malaria, said it was too early to declare victory.

It noted that the vaccine did not offer a complete shield, although trials -- including assessment of a booster shot -- are ongoing.

"This is good news as long as the vaccine shows a required level of efficacy," said John Gikapa, technical advisor to SANRU.

The research was carried out at 11 centres in seven African countries, covering more than 15,000 infants and children.

GSK said it would now file an application to the European Medicines Agency (EMA) under a process aimed at marketing new drugs for poorer countries.

The European medications watchdog will then give a "scientific opinion" on the vaccine's safety and efficacy.

This opens the way for it to be considered by the World Health Organisation (WHO), which in turn can fast-track its licensing in individual countries in Africa.

The vaccine -- called RTS,S -- is a frontrunner in the race to develop the first immunisation for malaria.

The results for the Phase III trial were unveiled Tuesday at a conference in South Africa.

They are sure to raise as many questions as answers.

As well as offering less protection for very small children, the vaccine's effectiveness declined over time, data showed.

"There are a number of possible hypotheses for these differences" in effectiveness, said Lucas Otieno of the Kenya Medical Research Institute, one of the principal investigators in the trial.

The theories include possible interference with the vaccine by maternal antibodies and the impact of other vaccines administered around the same time, he said.

'Any progress welcome'

Experts are also wary about the logistics of administering the vaccine in Africa, where the people most at risk often live in poverty-stricken and difficult-to-access places.

Just getting drugs to where they are needed can be a headache, requiring proper handling in hot, humid environments and secure storage in countries where theft or corruption may be rampant.

"Any progress on fighting malaria is very welcome, and this vaccine could be another important weapon in our armoury," said Martin de Smet, a malaria specialist with Doctors Without Borders (MSF).

"Delivering injection-based vaccines in the kind of environments where malaria is prominent is also hugely challenging -- even for treatments that are 100-percent effective," he said.

"Locations are traditionally remote, with people having to walk for days to get to a health facility, and often require refrigeration."

GSK said if it gets the green light, the vaccine would probably be distributed through agencies such as the United Nations Children's Fund and the GAVI Alliance, a public-private health partnership.

The price would cover the cost of manufacturing plus a margin of five percent which would be ploughed into research for next-generation vaccines, a GSK spokesman said.


 


AFP




  MENA News Headlines
 Feb 25 2017 - Qatar- Attack on Syrian security forces in Homs kills 42Gulf Times
(MENAFN - Gulf Times) The attackers killed the head of military security and 29 others at one of its headquarters in the city and 12 more people at a branch of state security in attacks that began ...

 Feb 25 2017 - Qatar- Bombs target oil pipeline in Iraq's Kirkuk, one killedGulf Times
(MENAFN - Gulf Times) The pipeline delivers crude from the Bai Hassan oilfield to a degassing station in Kirkuk, though pumping had been halted for maintenance at the time of the blasts, security ...

 Feb 25 2017 - Qatar- Boosting Erdogan powers will make 'strong Turkey': PMGulf Times
(MENAFN - Gulf Times) Yildirim spoke at the ruling party's first rally ahead of a key April 16 referendum, when the public will vote on whether to approve the changes creating an executive ...

 Feb 25 2017 - Hip and Knee Orthopedic Surgical Implants Market Size, Share, Analysis, Report and Forecast to 2022MENAFN Press
(MENAFN Editorial) Technological advancements and rising geriatric population worldwide are some of the key factors fueling the market growth. On the other hand, abridged reimbursements by insurance ...

 Feb 25 2017 - rfacil - An Israeli approach to Mexico's government mandated e-invoicing crossover, uniquely on both web and mobile, effecting 13.3 million taxpayersMENAFN Press
(MENAFN Editorial) iCrowdNewswire - Feb 22, 2017 rfacilAn Israeli approach to Mexico's government mandated e-invoicing crossover, uniquely on both web and mobile, effecting 13.3 million taxpayers ...

 Feb 25 2017 - BEIRUT, LADY OF LEBANON: A Theatrical Production Celebrating the Lebanese Culture and the Human Spirit in Time of WarMENAFN Press
(MENAFN Editorial) iCrowdNewswire - Feb 22, 2017 BEIRUT, LADY OF LEBANONA Theatrical Production Celebrating the Lebanese Culture and the Human Spirit in Time of War. About this project ...

 Feb 25 2017 - Arava announces shampoo with botanical ingredients that enrich skin and coat of dogsMENAFN Press
(MENAFN Editorial) Product provides skin nourishment, fights fungi and bacteria, and treat dermatological condition Arava announces Skin and Coat Intensive Bio-Care, an aromatherapy antibacterial, ...

 Feb 25 2017 - Jordan- Turkey says only 100 extremists left in Daesh-held Syria battlegroundJordan Times
(MENAFN - Jordan Times) ISTANBUL — Turkey said on Wednesday fewer than 100 extremists were still holed up in the flashpoint Daesh terror group Syrian town of Al Bab, as rebel commanders predicted its ...

 Feb 25 2017 - Jordan- 13 Europe-bound migrants suffocate in Libya containerJordan Times
(MENAFN - Jordan Times) TRIPOLI — The bodies of 13 migrants, including two teenagers, who died of suffocation in a shipping container bound for Europe have been found in Libya and 56 survivors ...

 Feb 25 2017 - Jordan- Why does the capture of Syria's Al Bab matter?Jordan Times
(MENAFN - Jordan Times) The town, whose name means 'The Gate', had an estimated prewar population of some 100,000 but was the target of an over three-month assault by Turkey and allied rebel forces ...

more...


 





Google

 
 

Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  
 

Middle East North Africa - Financial Network
Arabic MENAFN

Main News
News By Industry
News By Country

Search News
Market Indices
Quotes & Charts

Global Indices
Arab Indices

Commodoties

Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks
 

Algeria 
Bahrain 
Egypt 
Iraq
Jordan 
Kuwait 
Lebanon
Morocco 
Oman 
Palestine
Qatar 
Saudi Arabia 
Syria
Tunisia 
UAE 
Yemen

Weather
Economic Calendar
Financial Glossary


Financial Calculators

RSS Feeds [XML]

Corporate Monitor

Events

Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters


 
© 2014 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help